Previous Close | 0.6000 |
Open | 0.6000 |
Bid | 0.6100 x N/A |
Ask | 0.6600 x N/A |
Day's Range | 0.6000 - 0.6000 |
52 Week Range | 0.5000 - 1.6000 |
Volume | |
Avg. Volume | 6,804 |
Market Cap | 39.582M |
Beta (5Y Monthly) | -0.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0550 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the appointment of Smoke Wallin to the Company's board of directors.
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") is pleased to announce that it has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021, both of which are available at www.sedar.com.
Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company"), a Health Canada Licensed cannabis company focused on processing, sales, organoleptic testing, and analytical testing, is pleased to announce the submission of its Medical Sales License application to Health Canada on April 1, 2022.